SuperworthImmunic market cap IMUX
Share price times shares outstanding: what the whole company sells for, since 2014.
- Today, Oct 23, 2026
- $101.1M
- Highest close in our data
- $704.7M
- Apr 2015
Immunic is worth $101.1M at the close on Oct 23, 2026, at $7.41 a share.
That is up 33% over the last year and down 59% over five years.
Its highest close in our data was $704.7M in Apr 2015.
Market cap over time
Year by year
| Year | End of year | Low | High | Change |
|---|---|---|---|---|
| 2026 so far | $101.1M | $70.1M | $225.1M | +50% |
| 2025 | $67.5M | $63.2M | $114.4M | −27% |
| 2024 | $92.8M | $51.9M | $164.8M | +37% |
| 2023 | $67.7M | $47.3M | $114.1M | +23% |
| 2022 | $55M | $45.9M | $355.9M | −78% |
| 2021 | $251.2M | $192M | $431.1M | −21% |
| 2020 | $316.8M | $54.5M | $391.6M | +238% |
| 2019 | $93.8M | $8.3M | $171.7M | +1041% |
| 2018 | $8.2M | $7.2M | $398.3M | −97% |
| 2017 | $251.1M | $105.5M | $268M | +80% |
| 2016 | $139.4M | $139.4M | $287.1M | −60% |
| 2015 | $350.5M | $80.7M | $704.7M | −42% |
| 2014 | $607.8M | $261.5M | $700.4M | n/a |
Against its peers
Companies in Drug Manufacturers - General nearest Immunic's size, closest first, today.
| Company | Market cap |
|---|---|
| IMUXImmunic | $101.1M |
| LFVNLifevantage | $73.4M |
| SPROSpero Therapeutics | $64.6M |
| NATRNatures Sunshine Products | $213.8M |
| ATNMActinium Pharmaceuticals | $47.8M |
| ARVNArvinas | $477.3M |
| PBYIPuma Biotechnology | $568.9M |
| IRWDIronwood Pharmaceuticals | $571.7M |
| ZVRAZevra Therapeutics | $582.6M |
| CRMDCorMedix | $611.9M |
| COLLCollegium Pharmaceutical | $747.5M |
| Peer median | $523.1M |
What the market cap tells you
Share price times shares outstanding: what the whole company sells for today.
Size, not quality. Large caps move slower and are covered more. That is all it tells you.
More on Immunic
Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.